Hematology
News
FDA approves rivaroxaban for VTE prevention in hospitalized, acutely ill patients
The latest approval is based on results from the phase 3 MAGELLAN and MARINER trials, which included more than 20,000 patients.
News
New consensus recommendations on bleeding in acquired hemophilia
The key areas addressed in the global expert consensus statement include the initial management of bleeding and management of location-specific...
News
Best treatment approach for early stage follicular lymphoma is unclear
Overall survival rates were similar with different treatment approaches, including watchful waiting.
Conference Coverage
What is the optimal duration of maintenance in myeloma?
SAN FRANCISCO – Dr. Yvonne A. Efebera and Dr. Nina Shah debate whether patients with multiple myeloma should receive maintenance until progression...
Article
Primary care for the declining cancer survivor
Asking yourself 1 question can help you to estimate an advanced cancer patient’s prognosis and determine how best to help in setting end-of-life...
Outcomes Research in Review
AUGMENT: Lenalidomide/Rituximab vs Placebo/Rituximab in Relapsed or Refractory Indolent Lymphoma
Clinical Review
Role of Yoga Across the Cancer Care Continuum: From Diagnosis Through Survivorship
Clinical Review
Aplastic Anemia: Diagnosis and Treatment
News
Novel research aims to improve ED care in sickle cell disease
Researchers are testing the best acute pain management strategies to respond to a vasoocclusive crisis.
News
Q&A: Drug costs and value in cancer
Dr. Richard L. Schilsky, chief medical officer at ASCO, tackles the issue of how to determine the value of cancer drugs.